These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2596346)

  • 1. Serum dopamine-beta-hydroxylase activity in clinical subtypes of depression.
    Sapru MK; Rao BS; Channabasavanna SM
    Acta Psychiatr Scand; 1989 Nov; 80(5):474-8. PubMed ID: 2596346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum dopamine-beta-hydroxylase activity in psychotic and nonpsychotic major depression: the importance of distinguishing between unipolar and bipolar disorder.
    Rihmer Z; Arato M
    Acta Psychiatr Scand; 1990 Jul; 82(1):93-4. PubMed ID: 2399830
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum DBH activity in psychotic vs. nonpsychotic unipolar and bipolar depression.
    Mód L; Rihmer Z; Magyar I; Arató M; Alföldi A; Bagdy G
    Psychiatry Res; 1986 Dec; 19(4):331-3. PubMed ID: 3809331
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine-beta-hydroxylase and its apparent endogenous inhibitory activity in the plasma of some psychiatric patients.
    Yu PH; O'Sullivan KS; Keegan D; Boulton AA
    Psychiatry Res; 1980 Oct; 3(2):205-10. PubMed ID: 6947313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia. Decreased activity in unipolar psychotically depressed patients.
    Meltzer HY; Cho HW; Carroll BJ; Russo P
    Arch Gen Psychiatry; 1976 May; 33(5):585-91. PubMed ID: 1267575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum dopamine-beta-hydroxylase in diagnostic subgroups of depressed patients and in relation to their personality characteristics.
    Eisemann M; Ericsson U; Von Knorring L; Perris C; Perris H; Ross S
    Neuropsychobiology; 1983; 9(4):193-6. PubMed ID: 6646390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. III. Dopamine beta-hydroxylase (DBH) activity in the serum].
    Matsumoto H; Pacyna M; Pietruszewska I; Lewicka-Wysocka H
    Psychiatr Pol; 1983; 17(1):19-23. PubMed ID: 6622589
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma dopamine-beta-hydroxylase in depressed patients.
    Matuzas W; Meltzer HY; Uhlenhuth EH; Glass RM; Tong C
    Biol Psychiatry; 1982 Dec; 17(12):1415-24. PubMed ID: 7159639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. I. Plasma dopamine-beta-hydroxylase activity in endogenous depression.
    Puzynski S; Rode A; Zaluska M
    Acta Psychiatr Scand; 1983 Feb; 67(2):89-95. PubMed ID: 6846042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-beta-hydroxylase in the cerebrospinal fluid of psychiatric patients.
    Lerner P; Goodwin FK; van Kammen DP; Post RM; Major LF; Ballenger JC; Lovenberg W
    Biol Psychiatry; 1978 Dec; 13(6):685-94. PubMed ID: 737256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum DBH and platelet MAO in patients with depressive disorders.
    Honecker H; Fähndrich E; Coper H; Helmchen H
    Pharmacopsychiatria; 1981 Jan; 14(1 Suppl):10-4. PubMed ID: 7248043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum dopamine-beta-hydroxylase activity and lateral ventricular size in affective disorders and schizophrenia.
    Meltzer HY; Tong C; Luchins DJ
    Biol Psychiatry; 1984 Oct; 19(10):1395-402. PubMed ID: 6335052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of dopamine-beta-hydroxylase (DBH) and monoamine oxidase (MAO) activities in platelets and plasma in schizophrenic, maniac-depressive and neurotic patients].
    Xavier Vieira R; Azevedo M; Polónio P; Manso C
    Acta Med Port; 1986; 7(1):45-8. PubMed ID: 3728081
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of dopamine β-hydroxylase polymorphism rs1611115 and serum levels with psychiatric disorders in Pakistani population.
    Hashmi AN; Ahmed Dharejo R; Zubair UB; Khan N; Kashif I; Ajmal M; Taj R; Qamar R; Azam M
    Int J Neurosci; 2024 Jun; 134(6):551-559. PubMed ID: 36120985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum dopamine-beta-hydroxylase activity in schizophrenia.
    Meltzer HY; Nasr SJ; Tong C
    Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum dopamine-beta-hydroxylase activity in patients with major depressive disorders.
    Kjellman BF; Beck-Friis J; Ljunggren JG; Ross SB; Undén F; Wetterberg L
    Acta Psychiatr Scand; 1986 Mar; 73(3):266-70. PubMed ID: 3716844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma dopamine beta-hydroxylase activity in psychotic and non-psychotic post-traumatic stress disorder.
    Hamner MB; Gold PB
    Psychiatry Res; 1998 Feb; 77(3):175-81. PubMed ID: 9707300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum dopamine-beta-hydroxylase activity in depression and anxiety.
    Friedman MJ; Stolk JM; Harris PQ; Cooper TB
    Biol Psychiatry; 1984 Apr; 19(4):557-70. PubMed ID: 6733175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ; Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma dopamine-beta-hydroxylase in depressed patients and controls.
    Roy A; Brockington K
    Neuropsychobiology; 1987; 18(2):57-9. PubMed ID: 3451077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.